Results of the ROTAVAC Rotavirus Vaccine Study in India
Thursday, May 16, 2013
Statement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health.
Halo Pharma Announces Investment and Formal Collaboration with Altus
Thursday, May 16, 2013
Halo Pharma has taken a minority ownership position in, and established a formal collaboration with, Altus Formulation Inc.
Navidea Biopharmaceuticals Signs Agreement with Nordion
Thursday, May 16, 2013
Nordion to produce and distribute supplies of 123I-labeled drug product NAV5001 for late-phase clinical trials.
Bend Research Expands Analytical Sciences Capabilities
Wednesday, May 15, 2013
Bend Research Inc. announced that it has expanded its Good Manufacturing Practice (GMP) analytical capabilities and capacity for pharmaceutical development.
Agilent Technologies Introduces Verified Dissolution Components for Pharmaceutical Market
Wednesday, May 15, 2013
Agilent Technologies Inc. introduced a new series of verified dissolution components, including molded vessels as well as paddle and basket shafts.
BBSRC is Major Partner in Europe-wide Synthetic Biology Funding
Tuesday, May 14, 2013
BBSRC is contributing €3M as a major partner in a new call for research projects in Synthetic Biology.
FDA Accepts Biogen Idec’s Biologics License Application
Tuesday, May 14, 2013
ELOCTATE™ has potential to provide long-lasting protection and markedly reduce treatment burden for patients.
Cobra Biologics and Vaccibody Sign Agreement to Manufacture DNA Vaccine
Tuesday, May 14, 2013
Companies announce agreement to manufacture Vaccibody’s lead DNA vaccine candidate against HPV-induced malignancies.
PMMI and ISPE Partner to Launch Pharma EXPO
Monday, May 13, 2013
New pharmaceutical processing and packaging event to co-locate with PACK EXPO International 2014.
|
|
|
|
|
|
